Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.

At cardiology conferences and diabetes meetings, doctors can’t help noticing that thin seems to be very in.

The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower growth this year.

Doctors warn about their physical side effects, but they can also have unexpected effects on intimacy.

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.

An international commission made the case for focusing on body fat quantity and the illnesses people experience.